AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $177.93 million. The enterprise value is $206.83 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 30.49 million shares outstanding. The number of shares has increased by 2.60% in one year.
| Current Share Class | 30.49M |
| Shares Outstanding | 30.49M |
| Shares Change (YoY) | +2.60% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 1.83% |
| Owned by Institutions (%) | 25.51% |
| Float | 29.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.04 |
| Forward PS | 1.94 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58
| Current Ratio | 0.58 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.22 |
Financial Efficiency
Return on equity (ROE) is -935.73% and return on invested capital (ROIC) is -58.02%.
| Return on Equity (ROE) | -935.73% |
| Return on Assets (ROA) | -40.03% |
| Return on Invested Capital (ROIC) | -58.02% |
| Return on Capital Employed (ROCE) | 1,046.08% |
| Revenue Per Employee | $288,015 |
| Profits Per Employee | -$198,358 |
| Employee Count | 260 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, AVITA Medical has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.13% in the last 52 weeks. The beta is 1.58, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | -43.13% |
| 50-Day Moving Average | 5.17 |
| 200-Day Moving Average | 7.95 |
| Relative Strength Index (RSI) | 60.29 |
| Average Volume (20 Days) | 1,239,691 |
Short Selling Information
| Short Interest | 4.60M |
| Short Previous Month | 5.38M |
| Short % of Shares Out | 17.14% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.99 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $74.88 million and -$51.57 million in losses. Loss per share was -$1.97.
| Revenue | 74.88M |
| Gross Profit | 63.11M |
| Operating Income | -46.74M |
| Pretax Income | -57.01M |
| Net Income | -51.57M |
| EBITDA | -44.95M |
| EBIT | -46.74M |
| Loss Per Share | -$1.97 |
Full Income StatementBalance Sheet
The company has $15.69 million in cash and $44.59 million in debt, giving a net cash position of -$28.90 million or -$0.95 per share.
| Cash & Cash Equivalents | 15.69M |
| Total Debt | 44.59M |
| Net Cash | -28.90M |
| Net Cash Per Share | -$0.95 |
| Equity (Book Value) | -12.89M |
| Book Value Per Share | -0.48 |
| Working Capital | -26.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$35.83 million and capital expenditures -$6.12 million, giving a free cash flow of -$41.95 million.
| Operating Cash Flow | -35.83M |
| Capital Expenditures | -6.12M |
| Free Cash Flow | -41.95M |
| FCF Per Share | -$1.38 |
Full Cash Flow StatementMargins
Gross margin is 84.28%, with operating and profit margins of -62.42% and -68.87%.
| Gross Margin | 84.28% |
| Operating Margin | -62.42% |
| Pretax Margin | -68.87% |
| Profit Margin | -68.87% |
| EBITDA Margin | -60.02% |
| EBIT Margin | -62.42% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.60% |
| Shareholder Yield | -2.60% |
| Earnings Yield | -28.99% |
| FCF Yield | -23.58% |
Analyst Forecast
The average price target for AVITA Medical is $13.75, which is 135.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.75 |
| Price Target Difference | 135.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 40.59% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
AVITA Medical has an Altman Z-Score of -9.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.05 |
| Piotroski F-Score | 2 |
